GFAP and glioblastoma: Furthermore, graphene oxide (GO), a new carbon material, has been reported to have potential for use in GBM treatment, as GO could decrease the expression of stem cell markers such as SOX2 and CD133, and increase the expression of differentiation-related markers such as GFAP and β-III tubulin, ultimately inducing the differentiation of GSCs (173).